Hepatitis A outbreak in HIV-infected patients in Southeastern France: questions and responses?


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
17 04 2020
Historique:
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 18 7 2020
Statut: epublish

Résumé

During the 2017 European hepatitis A (HA) outbreak we assessed HA incidence in our cohort of 2300 HIV-infected patients, implemented preventive measures and evaluated practices and knowledge on sexually transmitted diseases (STD). HA incidence was assessed between 1 January 2017 and 31 December 2017 and included all symptomatic patients with virologically confirmed HA. Preventive measures consisted in identifying at risk and not immunised patients to propose them a free HAV vaccination, and an anonymous survey related to transmission routes of STD and to sexual behaviours. Twenty HA were diagnosed. All were homosexual men recently diagnosed with HIV and another STD. None were vaccinated against hepatitis A virus (HAV). Hospitalisation was required for 52%. We identified 250 patients at risk to acquire HAV and invited them to a free immunisation program. A total of 110 (44%) were vaccinated, of whom 74 responded to our survey. A majority of them (84%) reported recent active anal and oral sexuality with multiple (52%) male partners (81%), and ChemSex consumption (14%). Internet was the meeting link for 58%. Another STD history was found in 69%. One third of these individuals had no idea about STD transmission modes. This HA outbreak pointed the insufficient vaccine coverage against HAV and knowledge on STD, which may be improved by Internet.

Identifiants

pubmed: 32299522
doi: 10.1017/S0950268820000345
pii: S0950268820000345
pmc: PMC7189213
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e79

Références

Clin Infect Dis. 2018 Oct 30;67(10):1595-1602
pubmed: 29672699
J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):80-5
pubmed: 12514418
AIDS Rev. 2018 Jan-Mar;20(1):71
pubmed: 29628512
AIDS Rev. 2017 Apr - Jun;19(2):113-114
pubmed: 28534888
Liver Int. 2018 May;38(5):955-956
pubmed: 29282863
Euro Surveill. 2017 Nov;22(48):
pubmed: 29208161
BMJ Case Rep. 2018 Jan 11;2018:
pubmed: 29326373
Glob Health Action. 2016 Sep 19;9:32193
pubmed: 27649758
J Infect Dis. 1997 Oct;176(4):1064-7
pubmed: 9333168
J Biomed Res. 2016 Mar;30(2):101-111
pubmed: 28276665

Auteurs

A Martin (A)

Aix-Marseille Université, Institut de Recherche pour le Développement IRD, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Microbes, Evolution, Phylogeny and Infection (MEΦI), Marseille, France.

L Meddeb (L)

Aix-Marseille Université, Institut de Recherche pour le Développement IRD, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Microbes, Evolution, Phylogeny and Infection (MEΦI), Marseille, France.

J C Lagier (JC)

Aix-Marseille Université, Institut de Recherche pour le Développement IRD, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Microbes, Evolution, Phylogeny and Infection (MEΦI), Marseille, France.
Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005Marseille, France.

P Colson (P)

Aix-Marseille Université, Institut de Recherche pour le Développement IRD, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Microbes, Evolution, Phylogeny and Infection (MEΦI), Marseille, France.
Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005Marseille, France.

A Menard (A)

Aix-Marseille Université, Institut de Recherche pour le Développement IRD, Assistance Publique - Hôpitaux de Marseille (AP-HM), Marseille, France.
Microbes, Evolution, Phylogeny and Infection (MEΦI), Marseille, France.
Institut Hospitalo-Universitaire (IHU) - Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH